Insider Transactions in Q3 2022 at In8 Bio, Inc. (INAB)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.52%
|
$50,000
$2.02 P/Share
|
|
Sep 28
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.52%
|
$50,000
$2.02 P/Share
|
|
Aug 29
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.83%
|
$80,000
$2.02 P/Share
|
|
Aug 29
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.83%
|
$80,000
$2.02 P/Share
|
|
Aug 26
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,214
+0.23%
|
$22,428
$2.01 P/Share
|
|
Aug 26
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,214
+0.23%
|
$22,428
$2.01 P/Share
|
|
Aug 17
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.04%
|
$50,000
$1.93 P/Share
|
|
Aug 17
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.04%
|
$50,000
$1.93 P/Share
|
|
Aug 16
2022
|
Kate Rochlin Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,263
+50.0%
|
$5,263
$1.9 P/Share
|
|
Aug 16
2022
|
Patrick Mc Call CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
5,263
+50.0%
|
$5,263
$1.9 P/Share
|
|
Aug 16
2022
|
Lawrence Lamb EVP and CSO |
BUY
Open market or private purchase
|
Direct |
526
+0.52%
|
$526
$1.9 P/Share
|
|
Aug 16
2022
|
Alan S. Roemer |
BUY
Open market or private purchase
|
Direct |
26,315
+31.97%
|
$26,315
$1.9 P/Share
|
|
Aug 16
2022
|
William Tai Wei Ho PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
26,315
+1.12%
|
$26,315
$1.9 P/Share
|
|
Aug 16
2022
|
Luba Greenwood |
BUY
Open market or private purchase
|
Direct |
526
+6.3%
|
$526
$1.9 P/Share
|
|
Aug 16
2022
|
Trishna Goswami Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,631
+50.0%
|
$2,631
$1.9 P/Share
|
|
Aug 16
2022
|
Emily Fairbairn |
BUY
Open market or private purchase
|
Indirect |
789,473
+16.11%
|
$789,473
$1.9 P/Share
|
|
Aug 16
2022
|
Peter C. Brandt |
BUY
Open market or private purchase
|
Direct |
105,263
+36.58%
|
$105,263
$1.9 P/Share
|
|
Aug 16
2022
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,773,684
+35.02%
|
$1,773,684
$1.9 P/Share
|
|
Aug 16
2022
|
Aaron G.L. Fletcher > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,773,684
+35.02%
|
$1,773,684
$1.9 P/Share
|